TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7719564

Group type: EXPERIMENTAL
Intervention: Computer-based eligibility screening system
Number of subjects: 60
Study: 2039045

Group type: EXPERIMENTAL
Intervention: Preoperative 0.03% flurbiprofen every 30 minutes for four doses
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 6981162

Group type: EXPERIMENTAL
Intervention: Single dose of two double-strength trimethoprim-sulfamethoxazole (TMP-SMZ) tablets (320 mg of TMP and 1,600 mg of SMZ)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional therapy of one double-strength tablet (160 mg of TMP and 800 mg of SMZ) twice a day for 10 days
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Single-dose therapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 104
Study: 30801436

Group type: EXPERIMENTAL
Intervention: Exercise Training Group (ETG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study: 28686776

Group type: EXPERIMENTAL
Intervention: A/BPO gel 0.3%/2.5%
Number of subjects: 217

Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 217
Study: 26329939

Group type: EXPERIMENTAL
Intervention: Topical Tacrolimus 0.03% twice daily for three weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1% Hydrocortisone acetate for three weeks
Number of subjects: 60
Study: 24862764

Group type: EXPERIMENTAL
Intervention: Exergaming (Wii Fit training)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional weight-shift training (Control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (Exergaming and Control)
Number of subjects: 30
Study: 21658805

Group type: EXPERIMENTAL
Intervention: Topical sucralfate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 19755144

Group type: EXPERIMENTAL
Intervention: GMZ2 (10, 30, and 100 microg)
Number of subjects: 30
Study: 17313301

Group type: EXPERIMENTAL
Intervention: 1 g L-carnitine L-tartrate
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 2 g L-carnitine L-tartrate
Number of subjects: 8

Group type: COMPARATOR
Intervention: 0 g L-carnitine L-tartrate (control)
Number of subjects: 8
Study: 17055209

Group type: EXPERIMENTAL
Intervention: Madopar (200 mg levodopa and 50 mg benserazide)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15687727

Group type: EXPERIMENTAL
Intervention: Intravenous esomeprazole (injection) 40 mg once daily for 1 week, followed by oral esomeprazole 40 mg once daily for 3 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intravenous esomeprazole (infusion) 40 mg once daily for 1 week, followed by oral esomeprazole 40 mg once daily for 3 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral esomeprazole 40 mg once daily for 4 weeks
Number of subjects: 100
Study: 11218319

Group type: EXPERIMENTAL
Intervention: Enhanced care (intervention)
Number of subjects: 479
Study: 9179508

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (10-40% concentration)
Number of subjects: 19
Study: 8233728

Group type: EXPERIMENTAL
Intervention: High caloric supplement (500 kcal/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low caloric supplement (140 kcal/d)
Number of subjects: 0
Study: 3898976

Group type: EXPERIMENTAL
Intervention: Pivampicillin 700 mg twice daily for 6 days
Number of subjects: 86

Group type: COMPARATOR
Intervention: Metronidazole 400 mg three times daily for 7 days
Number of subjects: 86
Study: 31476994

Group type: EXPERIMENTAL
Intervention: App-controlled feedback devices (BIA scale, blood pressure monitor, step counter)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Mechanical pedometer without app
Number of subjects: 89
Study: 27779777

Group type: EXPERIMENTAL
Intervention: Usual care plus text-only behaviour change technique-based intervention
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Usual care plus text + visual behaviour change technique-based intervention
Number of subjects: 177

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 177
Study: 25794603

Group type: EXPERIMENTAL
Intervention: Combination of dabrafenib and trametinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dabrafenib monotherapy
Number of subjects: 0
Study: 23829035

Group type: COMPARATOR
Intervention: Conventional laparoscopic ports
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LESS devices
Number of subjects: 0
Study: 21497843

Group type: EXPERIMENTAL
Intervention: Burch colposuspension
Number of subjects: 66

Group type: COMPARATOR
Intervention: Pelvic organ prolapse repair alone
Number of subjects: 66
Study: 18783414

Group type: EXPERIMENTAL
Intervention: Porcelain fused to TiAdapt titanium abutments (test)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Cement crowns onto CeraOne abutments (control)
Number of subjects: 35
Study: 16317803

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15226337

Group type: COMPARATOR
Intervention: Conventionally fractionated cranial radiation therapy (CFX)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Hyperfractionated cranial radiation therapy (HFX)
Number of subjects: 369
Study: 11477497

Group type: EXPERIMENTAL
Intervention: 4.2 g CLA/day
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 10437461

Group type: EXPERIMENTAL
Intervention: Motivational intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Knowledge-supplied intervention
Number of subjects: 22
Study: 7822600

Group type: COMPARATOR
Intervention: Routine oral thermometry (CRAFTEMP)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Optimum oral thermometry (TERUMO WCT)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Routine rectal thermometry (TERUMO WCT)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Optimum rectal thermometry (TERUMO WCT)
Number of subjects: 275
Study: 3168766

Group type: EXPERIMENTAL
Intervention: 2 mg dexamethasone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Total abstinence
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Abnormal DST response
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hepatic status
Number of subjects: 50
Study: 30938764

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Not assessable
Number of subjects: 37
Study: 28329124

Group type: EXPERIMENTAL
Intervention: Interns working extended overnight shifts
Number of subjects: 224

Group type: COMPARATOR
Intervention: Residents not working overnight shifts
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Interns on on-call nights
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Interns after on-call nights
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Interns post-call naps
Number of subjects: 224
Study: 25705889

Group type: EXPERIMENTAL
Intervention: Nasal fluticasone propionate
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 48
Study: 23305402

Group type: EXPERIMENTAL
Intervention: Standard AVSH
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Enhanced AVSH
Number of subjects: 81

Group type: COMPARATOR
Intervention: Fixed atrioventricular delay
Number of subjects: 81
Study: 21424338

Group type: EXPERIMENTAL
Intervention: TRIM-Diabetes (TRIM-D)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TRIM-Diabetes Device (TRIM-DD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TRIM-D and TRIM-DD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internal consistency of TRIMs
Number of subjects: 0
Study: 18071344

Group type: EXPERIMENTAL
Intervention: Habit-based intervention (n=69, with subgroups of n=33 for weekly weighing and n=36 for monthly weighing)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Habit-based intervention (n=69)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Waiting-list control (n=35)
Number of subjects: 104
Study: 16421649

Group type: EXPERIMENTAL
Intervention: Expressive writing about deepest thoughts and feelings about living with HIV
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group writing about activities in the last 24 hours
Number of subjects: 79
Study: 10937312

Group type: EXPERIMENTAL
Intervention: Sleep loss participants (29-50 hr)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (n = 45)
Number of subjects: 93
Study: 9346982

Group type: COMPARATOR
Intervention: Tetracaine-adrenaline-cocaine (TAC)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Prilocaine-phenylephrine
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Tetracaine-lidocaine-phenylephrine
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Tetraphen
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Three new topical anesthetics (prilocaine-phenylephrine, tetracaine-phenylephrine, tetracaine-lidocaine-phenylephrine)
Number of subjects: 240
Study: 8478305

Group type: EXPERIMENTAL
Intervention: Dirithromycin (500 mg orally once daily)
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Erythromycin (250 mg orally qds)
Number of subjects: 1222
Study: 3006464

Group type: EXPERIMENTAL
Intervention: diatrizoate (ionic radiographic contrast agent)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: iopamidol (nonionic radiographic contrast agent)
Number of subjects: 46
Study: 30518693

Group type: EXPERIMENTAL
Intervention: Metformin (1,500 mg) + Saline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metformin (1,500 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ex vivo Metformin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 26343026

Group type: EXPERIMENTAL
Intervention: Gluten-Free/Casein-Free (GFCF) diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: Dietary challenges (gluten, casein, gluten and casein, or placebo)
Number of subjects: 14
Study: 25562774

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care intervention (usual care plus pharmaceutical care)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 200
Study: 22987572

Group type: COMPARATOR
Intervention: 5 mg rosuvastatin
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: 40 mg rosuvastatin
Number of subjects: 87
Study: 20932368

Group type: EXPERIMENTAL
Intervention: Trocar fitted with a spiral thread on the sleeve (Group A)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Trocar with plain sleeve (Group B)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Trocar with plain sleeve + fixator (Group C)
Number of subjects: 131
Study: 18236371

Group type: EXPERIMENTAL
Intervention: FK 506 eye drops 3 x /day for six months
Number of subjects: 40

Group type: COMPARATOR
Intervention: prednisolone acetate 1 % eye drops 5 x /day, tapering off by one drop every month
Number of subjects: 40
Study: 16487668

Group type: EXPERIMENTAL
Intervention: Prison methadone treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prison methadone
Number of subjects: 0
Study: 14723479

Group type: EXPERIMENTAL
Intervention: Active nicotine patch therapy (n = 2)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo patch therapy (n = 4)
Number of subjects: 7
Study: 10753692

Group type: EXPERIMENTAL
Intervention: Surgeons changed the gloves before the first contact with the vascular prosthesis (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Operation without glove change (Group 2)
Number of subjects: 40
Study: 9298322

Group type: EXPERIMENTAL
Intervention: Left visual field stimulation (LVF)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Right visual field stimulation (RVF)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Experimental goggles (LVF and RVF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control goggles (monocular vision)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Experimental goggles
Number of subjects: 70
Study: 8334003

Group type: EXPERIMENTAL
Intervention: Inferior pharyngeal constrictor myotomy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Herrmann technique
Number of subjects: 122

Group type: COMPARATOR
Intervention: Classic total laryngectomy
Number of subjects: 122
Study: 3089407

Group type: EXPERIMENTAL
Intervention: Inpatient withdrawal programme
Number of subjects: 60

Group type: COMPARATOR
Intervention: Outpatient withdrawal programme
Number of subjects: 60
Study: 30276101

Group type: EXPERIMENTAL
Intervention: Interlaminar stabilization (ILS)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Fusion
Number of subjects: 116
Study: 27227406

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention (educational lectures, posters, pocket cards, computerized clinical decision support systems, electronic reminders)
Number of subjects: 1402

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1402

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 1402

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1402
Study: 25999980

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Donepezil, Rivastigmine, Galantamine
Number of subjects: 55
Study: 23290791

Group type: EXPERIMENTAL
Intervention: Aripiprazole plus lithium or valproate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus lithium or valproate
Number of subjects: 0
Study: 20533241

Group type: EXPERIMENTAL
Intervention: GPLC (4.5 g/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 19035097

Group type: EXPERIMENTAL
Intervention: Tones of 0.5, 2 or 4 kHz amplitude modulated (AM) sinusoidally at 8 Hz presented at 96 dB SPL
Number of subjects: 16
Study: 16847171

Group type: EXPERIMENTAL
Intervention: GHK-Cu skin care products
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (no GHK-Cu)
Number of subjects: 13
Study: 14667955

Group type: EXPERIMENTAL
Intervention: Olopatadine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12050837

Group type: EXPERIMENTAL
Intervention: Relaxation
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Combination of relaxation and music
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) with interventions
Number of subjects: 311

Group type: COMPARATOR
Intervention: Control group (PCA alone)
Number of subjects: 311
Study: 10630656

Group type: EXPERIMENTAL
Intervention: Age adjusted warfarin loading protocol
Number of subjects: 186

Group type: COMPARATOR
Intervention: Fennerty's protocol
Number of subjects: 186

Group type: COMPARATOR
Intervention: Empirical dosing
Number of subjects: 186
Study: 7604666

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori positivity
Number of subjects: 1180

Group type: EXPERIMENTAL
Intervention: Age groups
Number of subjects: 1180

Group type: COMPARATOR
Intervention: Ethnic background
Number of subjects: 1180
Study: 1666684

Group type: EXPERIMENTAL
Intervention: High-dose naloxone (10 mg bolus plus 7 mg/hr)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 8
Study: 6462107

Group type: COMPARATOR
Intervention: Gentamicin alone (2 mg/kg IV)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Gentamicin with carbenicillin (2 g IV every 8 h for six doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Gentamicin with piperacillin (4 g IV every 12 h for four doses)
Number of subjects: 12
Study: 3840740

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (4 mg preservative-free morphine in 6 ml saline)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (anaesthetised without intrathecal morphine)
Number of subjects: 20
Study: 29422049

Group type: EXPERIMENTAL
Intervention: Multifaceted tailored intervention including clinician education, a specific website, and workshops for implementing cardiovascular guidelines.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual implementation of guidelines (by email, intranet, and clinical meetings).
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Multifaceted tailored intervention.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Multifaceted tailored intervention and usual implementation.
Number of subjects: 43
Study: 27998224

Group type: EXPERIMENTAL
Intervention: AZD1775 plus carboplatin
Number of subjects: 24
Study: 25772920

Group type: EXPERIMENTAL
Intervention: Re-wetting agent with 37% phosphoric acid etching
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Re-wetting agent with Erbium: Yttrium aluminium garnet laser etching
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group with 37% phosphoric acid etching
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group with Erbium: Yttrium aluminium garnet laser etching
Number of subjects: 24
Study: 23363041

Group type: EXPERIMENTAL
Intervention: Active e‐cigarette smoking
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Active tobacco cigarette smoking
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Passive e‐cigarette smoking
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Passive tobacco cigarette smoking
Number of subjects: 30
Study: 21122094

Group type: EXPERIMENTAL
Intervention: Short leaflet
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Long leaflet
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Technical information
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Diagrams
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 553
Study: 18691228

Group type: EXPERIMENTAL
Intervention: Intervention (Risk evaluation/communication programme)
Number of subjects: 1103

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 1103
Study: 16573545

Group type: EXPERIMENTAL
Intervention: Thymoglobulin induction, rapamycin (RAPA), and immunonutrients (arginine and omega-3 fatty acids); Mycophenolate mofetil (MMF) started in standard doses and discontinued by 2 years; CsA given in reduced doses for either 4, 6, or 12 months.
Number of subjects: 96
Study: 14518801

Group type: EXPERIMENTAL
Intervention: Nine interventions
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 1222
Study: 10715225

Group type: EXPERIMENTAL
Intervention: Sorbitol 40 g/day in candy
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Olestra 20 g/day in potato chips
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Olestra 40 g/day in potato chips
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 9177920

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 60

Group type: COMPARATOR
Intervention: D-penicillamine (DP)
Number of subjects: 60
Study: 8268900

Group type: EXPERIMENTAL
Intervention: Active treatment (nitrendipine, possibly with a converting-enzyme inhibitor and a thiazide)
Number of subjects: 1395

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1395
Study: 3082592

Group type: EXPERIMENTAL
Intervention: 250 micrograms levonorgestrel + 50 micrograms ethinyloestradiol (LN 250 + EE 50)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 250 micrograms levonorgestrel + 30 micrograms ethinyloestradiol (LN 250 + EE 30)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1 mg norethisterone acetate + 50 micrograms ethinyloestradiol (NA 1 + EE 50)
Number of subjects: 0
Study: 28929486

Group type: EXPERIMENTAL
Intervention: Migraine
Number of subjects: 146614
Study: 26692079

Group type: EXPERIMENTAL
Intervention: Conventional mechanical ventilation
Number of subjects: 171

Group type: COMPARATOR
Intervention: High-frequency oscillation
Number of subjects: 171
Study: 24397906

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM plus routine vaccines
Number of subjects: 7744

Group type: COMPARATOR
Intervention: Routine vaccines alone
Number of subjects: 7744
Study: 21549643

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 112
Study: 20014980

Group type: EXPERIMENTAL
Intervention: Intravenous iron supplementation (ferric carboxymaltose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral iron supplementation
Number of subjects: 0
Study: 18544424

Group type: EXPERIMENTAL
Intervention: Single dose of 270 microg/kg rFVIIa
Number of subjects: 0

Group type: COMPARATOR
Intervention: On-demand treatment schedules (multiple bolus doses of 90 to 120 microg/kg every 2 to 3 hours)
Number of subjects: 0
Study: 15915415

Group type: EXPERIMENTAL
Intervention: ECUS-assisted technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 100
Study: 12514656

Group type: EXPERIMENTAL
Intervention: Coronary blood flow in CAE group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Peak hyperemic average peak velocities (APVs) of coronary blood flow in CAE group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Volumetric coronary blood flow at rest in CAE group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Volumetric coronary blood flow at hyperemia in CAE group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Mean coronary flow reserve (CFR) in CAE group
Number of subjects: 17
Study: 10907364

Group type: EXPERIMENTAL
Intervention: Diabetic patients with complications (N1)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Diabetic patients without complications (N0)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Healthy controls (N0)
Number of subjects: 89
Study: 9013369

Group type: EXPERIMENTAL
Intervention: Codeine (60 mg administered orally)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Visual analog pain ratings
Number of subjects: 6
Study: 1568521

Group type: EXPERIMENTAL
Intervention: Intra-articular rifamycin SV (525 mg/week) for 10 weeks
Number of subjects: 116

Group type: COMPARATOR
Intervention: Auranofin (3 mg orally twice daily)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Intra-articular rifamycin SV
Number of subjects: 116

Group type: COMPARATOR
Intervention: Auranofin
Number of subjects: 116
Study: 3883908

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31763263

Group type: EXPERIMENTAL
Intervention: Nasya Group
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Nasya + Oral Group
Number of subjects: 61

Group type: COMPARATOR
Intervention: Controlled Group
Number of subjects: 61